Goldshleger Ilya's Form 4 filing
RxSight, Inc.RXST · filed Oct 15, 2024
- Accession no.
- 0000950170-24-114697
- Filed
- Oct 15, 2024
- Trade date
- Oct 10-14, 2024
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $462.5K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Goldshleger IlyaCIK 0001874147 | Officer (See remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 10, 2024 | Common Stock | MOption exerciseAcquired | +3,105 | $15.08 | +$46,823.4 | 45,351 | Direct | |
| Oct 10, 2024 | Common Stock | SSaleDisposed | −3,105 | $48.82F2 | −$151,586.1 | 42,246 | Direct | |
| Oct 11, 2024 | Common Stock | MOption exerciseAcquired | +3,100 | $15.08 | +$46,748 | 45,346 | Direct | |
| Oct 11, 2024 | Common Stock | SSaleDisposed | −3,100 | $50.19F3 | −$155,589 | 42,246 | Direct | |
| Oct 14, 2024 | Common Stock | MOption exerciseAcquired | +3,100 | $15.08 | +$46,748 | 45,346 | Direct | |
| Oct 14, 2024 | Common Stock | SSaleDisposed | −3,100 | $50.09F4 | −$155,279 | 42,246 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 10, 2024 | Common Stock | MOption exerciseDisposed | −3,105 | $0.00 | $0 | 90,397 | Direct | |
| Oct 11, 2024 | Common Stock | MOption exerciseDisposed | −3,100 | $0.00 | $0 | 87,297 | Direct | |
| Oct 14, 2024 | Common Stock | MOption exerciseDisposed | −3,100 | $0.00 | $0 | 84,197 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average share price of an aggregate total of 3,105 shares sold in the price range of $48.415 to $49.135 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average share price of an aggregate total of 3,100 shares sold in the price range of $49.73 to $50.47 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average share price of an aggregate total of 3,100 shares sold in the price range of $49.83 to $50.64 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
Remarks
Co-President and Chief Operating Officer